Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Iovance Biotherapeutics
Biotech
FDA lifts hold on Iovance's lung cancer cell therapy trial
Iovance ended 2023 on a downer courtesy of a partial clinical hold from the FDA, but the situation has been resolved relatively quickly.
James Waldron
Mar 4, 2024 9:44am
Iovance cell therapy trial hit with FDA hold after patient death
Dec 29, 2023 10:29am
FDA resource constraints delay decision on Iovance cell therapy
Sep 15, 2023 5:20am
Iovance gets FDA ok for accelerated review of lung cancer drug
Jul 10, 2023 10:40am
Iovance sinks as pivotal cell therapy data disappoint investors
May 27, 2022 8:27am
Path cleared for Iovance's melanoma drug after FDA feedback
Apr 6, 2022 10:35am